NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AS POTENTIAL RISK FACTOR OF CARDIOVASCULAR DISEASE AND ONCOLOGICAL DISEASE IN DIABETIC TYPE 2 PATIENTS

被引：0
|
作者：
Caroli, D. [1 ]
Nogara, A. [1 ]
Rosa-Rizzotto, E. [2 ]
Bariga, A. Boscolo [1 ]
Zanoni, S. [1 ]
De Boni, S. [1 ]
Cavallarin, G. [1 ]
Marafin, C. [1 ]
Inglese, M. [1 ]
Della Loggia, M. [1 ]
Peraro, L.
Lobello, S. [2 ]
De Lazzari, F. [2 ]
机构：
[1] Osped Chioggia, Internal Med, Chioggia, Italy
[2] OSp S Antonio, Gastroenterol, Padua, Italy
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30205-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP52
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [31] FOCUS ON THE TYPE 2 DIABETES PATIENT WITH LIVER DISEASE: EMPHASIS ON NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Cusi, Kenneth
    [J]. ENDOCRINE PRACTICE, 2011, 17 : 9 - 13
  • [32] Therapeutic Potential of Beta Hydroxybutyrate in Nonalcoholic Fatty Liver Disease (NAFLD)-Induced Cardiovascular
    Badmus, Olufunto O.
    Taylor, Lucy C.
    Greer, Jennifer R.
    McGowan, Karis E.
    Hinds, Terry
    Stec, David E.
    [J]. CIRCULATION, 2023, 148
  • [33] Risk of Nonalcoholic Fatty Liver Disease (NAFLD)-Related Liver Complications in the Diabetic Population in Israel
    Goldshtein, Inbal
    Fernandes, Gail
    Chodick, Gabriel
    Rajpathak, Swapnil
    Karasik, Avraham
    [J]. DIABETES, 2018, 67
  • [34] The Potential Role of Serum Endocan in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
    Elsheikh, Elzafir
    Younoszai, Zahra
    Hunt, Sharon L.
    Otgonsuren, Munkhzul
    Raybuck, Bryan
    Younossi, Zobair M.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S1022 - S1022
  • [35] Omega-6 Fatty Acid Level Is Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetic Patients
    Higa, Mariko
    Yamashita, Kaoru
    Yoshikawa, Fukumi
    Fuse, Yukie
    Ohira, Akeo
    Harada, Marina
    Ouchi, Hiromi
    Ichijo, Takamasa
    [J]. DIABETES, 2015, 64 : A209 - A209
  • [36] Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients
    Sima, Alexandra
    Timar, Romulus
    Vlad, Adrian
    Timar, Bogdan
    Rosu, Mihaela
    Dan, Isabel
    Sirli, Roxana
    Popescu, Alina
    Sporea, Ioan
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (11-12) : 335 - 340
  • [37] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    [J]. Hepatology International, 2013, 7 : 755 - 764
  • [38] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Duseja, Ajay
    Chalasani, Naga
    [J]. HEPATOLOGY INTERNATIONAL, 2013, 7 : S755 - S764
  • [39] NONALCOHOLIC FATTY LIVER DISEASE - A NEW CARDIOVASCULAR RISK FACTOR IN PERITONEAL DIALYSIS PATIENTS
    Mikolasevic, Ivana
    Racki, Sanjin
    Colic, Marina
    Devcic, Bosiljka
    Lukenda, Vesna
    Zaputovic, Luka
    Babic, Vesna
    Orlic, Lidija
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [40] Nonalcoholic fatty liver disease and cardiovascular disease
    Hong Liu
    Hong-yun Lu
    [J]. World Journal of Gastroenterology, 2014, (26) : 8407 - 8415
12345